WDAY · Workday, Inc. · Stock research

Current Thesis

For most of the first half of 2026 Workday traded as enterprise software's designated AI casualty: a seat-priced HCM and financials incumbent that autonomous agents were supposed to hollow out. The 2026-05-21 Q1 FY27 report pointed the other way — subscription revenue $2.354B (+14.3% YoY), 12-month subscription backlog (cRPO) $8.806B (+15.5% YoY), and full-year non-GAAP operating margin guidance raised to 30.5%. Price has followed: +40.5% over three months to a $179.64 close on 2026-08-07, while still 27.5% below the $247.69 52-week high.

The narrative leg on offer is a de-rating reversal, not a growth story. An investor is buying the claim that agentic AI arrives as expansion ACV inside a 27.294B total backlog rather than as seat compression, and that a ~30% margin base compounds while the multiple repairs. That claim gets exactly one datapoint inside the next month, on 2026-08-27.

Bullish and bearish views on Workday, Inc.

The model's bull view on Workday, Inc. (WDAY), in brief: Q1 FY27 (2026-05-21): cRPO $8.806B, +15.5% YoY — faster than the +14.3% subscription revenue growth and faster than total backlog's +10.9%. The bear view: The guided direction of the key metric is down. Both cases follow in full.

Bull Case

• Q1 FY27 (2026-05-21): cRPO $8.806B, +15.5% YoY — faster than the +14.3% subscription revenue growth and faster than total backlog's +10.9%. Near-term committed demand accelerated ahead of reported revenue.
• Margin guide raised, not defended. FY27 non-GAAP operating margin guidance moved to 30.5% at the Q1 print; Q1 itself delivered non-GAAP operating income of $809M on a 31.8% margin against GAAP operating income of $338M (13.3%).
• Agentic AI is showing up in the bookings mix, per management on 2026-05-21: more than 25% of new ACV in customer-base expansions came from AI, with AI-attached expansion deals averaging over 50% larger; agentic AI new ACV grew more than 200% YoY, and management characterized it as the best first quarter of new ACV growth in five years.
• The company was a size buyer into its own drawdown: approximately 12.0 million shares repurchased for $1.6B in the quarter ended 2026-04-30, against $4.353B of cash and marketable securities and $616M of Q1 free cash flow.
• Federal surface expanded 2026-07-23: Workday Government's Adaptive Planning received FedRAMP authorization at Moderate impact level, opening planning workloads at agencies that were previously procurement-blocked.

Bear Case

• The guided direction of the key metric is down. Q2 FY27 guidance issued 2026-05-21 calls for cRPO growth of 13.5–14.5%, a step below the 15.5% just printed. Q2 subscription revenue is guided to roughly $2.455B (+13%), and FY27 subscription revenue to $9.925–9.950B (12–13%) — deceleration from Q1's +14.3%.
• Duration is shortening. Total subscription backlog grew 10.9% YoY while cRPO grew 15.5%. Long-dated commitments are expanding materially slower than the 12-month book.
• Sell-side is split, and one house is dated and hostile: Morgan Stanley downgraded Workday to Underweight with a $145 price target on 2026-07-21 — a level below the 2026-08-07 close of $179.64. That call was made into, not before, the rally.
• The disruption headline is live. Business Insider reported on 2026-07-22 that OpenAI is launching corporate software extending it beyond the model layer. Nothing in Workday's disclosures dates a competitive loss to it, but the sector re-rating that took WDAY to its lows was built on exactly this class of story, and it has not been retired.
• Nothing fundamental has landed since 2026-05-21. The 40.5% three-month move is a multiple move on an unchanged set of numbers.

Setup & Price Structure

Life-cycle: ACCELERATING, dated to the leg off the early-May 2026 base (+40.5% over three months into the 2026-08-07 close of $179.64) and to fresh dated headlines — FedRAMP Moderate on 2026-07-23, the earnings date confirmation on 2026-08-03. The qualifier matters: this is a recovery leg inside a well-covered mega-cap, and price remains 27.5% under the $247.69 52-week high, so the move is repair rather than discovery. The label is fragile by construction — it is 19 days from a print that can retire it.

Positioning and crowding observables, stated as observables:

• RSI(14) 67.4 as of 2026-08-07 — extended, below the conventional 70 threshold, with no reading available here on how long it has been elevated.
• Distance structure is unusual: strongly positive three-month momentum coexisting with a 27.5% drawdown from the high. Both the momentum crowd and the value-recovery crowd can hold the same tape.
• Earnings inside the window: 2026-08-27 after the close, confirmed 2026-08-03. Any position taken now carries that print.
• Issuance/insider evidence is absent in the filings available for this window; what is filed is the opposite flow — the $1.6B Q1 repurchase disclosed 2026-05-21.
• A live bearish target sits ~19% under spot (Morgan Stanley $145, 2026-07-21), which is dispersion rather than consensus positioning.

Structurally, the recovery leg's give-back level is the thing to watch. A daily close below $160 would surrender the bulk of the advance built since early May and put the tape back inside the pre-rally range.

Catalyst Calendar (next 30 days)

• 2026-08-27 (confirmed) — Q2 FY27 results, after US market close; conference call 1:30 p.m. PT / 4:30 p.m. ET. Announced 2026-08-03. Resolves cRPO growth against the guided 13.5–14.5% band, subscription revenue against ~$2.455B, and whether the FY27 $9.925–9.950B subscription guide and 30.5% margin guide hold.
• 2026-08-27 (same call) — Q3 FY27 guidance and any update to the agentic-AI ACV disclosures management introduced on 2026-05-21.
• ~2026-09-01 (est.) — Q2 FY27 Form 10-Q, normally filed within days of the release. Carries the full backlog and deferred-revenue detail the press release compresses.

What Would Change Our Mind

The structure that would have to break first is the recovery leg itself: the advance off the early-May base is the only thing that has changed since 2026-05-21, and it rests on a multiple, not on a new number. A daily close below $160 marks that leg lost.

On fundamentals, the specific reversal is a 2026-08-27 print with cRPO growth beneath the guided 13.5–14.5% band, or an FY27 subscription revenue guide cut below the $9.925B floor set on 2026-05-21. Either would confirm that the 15.5% cRPO figure was a duration artifact rather than demand re-acceleration.

The narrative-side reversal is a named, dated competitive loss in HCM or financials attributed to an agent-native entrant on a public call — the concrete version of the 2026-07-22 OpenAI corporate-software headline. Conversely, cRPO printing above 14.5% on 2026-08-27 with the margin guide intact would strengthen the case that AI attaches to this installed base instead of eroding it.

Time-decay case: if 2026-08-27 comes and goes with an in-line print and the stock cannot hold its post-print level, the setup ages into a crowded recovery with no further dated resolution until the Q3 report.

Correlation Notes

• Enterprise SaaS complex. WDAY moves with the large-cap application-software cohort on the same dispute — whether agents expand or compress seat-based pricing. The 2026-07-29 Wells Fargo note raising Snowflake's target to $500 on the argument that AI agents raise customer spend is the same trade expressed in a different name.
• Inverse to the semiconductor tape, recently. Benzinga dated the Nasdaq 100's entry into correction to 2026-07-28 on a deepening chip rout, with an 8% oil crash and the chip decline erasing a relief rally on 2026-07-27. WDAY's three-month gain was built across that window. The inference — that capital rotated from AI hardware into de-rated software — is an inference, not a measurement; no flow data supports it here.
• Rate sensitivity remains structural. Long-duration software multiples track the front end; the Fed decision that overhung the 2026-07-27/28 tape is a sector-level input, not a company one.
• Idiosyncratic risk dominates for 19 days. Between now and 2026-08-27, the single-name earnings variable outweighs the sector beta in explaining what this ticker does.